(Q80341146)
Statements
Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma (English)
Thomas E Hutson
Luis Molto
Amy Richmond
Cheryl Nemec
Tarek Mekhail
Paul Elson
Charles Tannenbaum
Thomas Olencki
James Finke
Ronald M Bukowski